Morgan Stanley’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.7B | Sell |
|
|||||
2025
Q1 | $2.04B | Buy |
|
|||||
2024
Q4 | $1.96B | Sell |
|
|||||
2024
Q3 | $2.26B | Buy |
|
|||||
2024
Q2 | $2.17B | Sell |
|
|||||
2024
Q1 | $2.35B | Sell |
|
|||||
2023
Q4 | $4.73B | Buy |
|
|||||
2023
Q3 | $2.82B | Buy |
|
|||||
2023
Q2 | $3.1B | Buy |
|
|||||
2023
Q1 | $3.29B | Buy |
|
|||||
2022
Q4 | $4.07B | Buy |
|
|||||
2022
Q3 | $3.15B | Sell |
|
|||||
2022
Q2 | $3.8B | Buy |
|
|||||
2022
Q1 | $2.45B | Buy |
|
|||||
2021
Q4 | $2.78B | Buy |
|
|||||
2021
Q3 | $2.01B | Sell |
|
|||||
2021
Q2 | $1.88B | Buy |
|
|||||
2021
Q1 | $1.68B | Sell |
|
|||||
2020
Q4 | $1.97B | Buy |
|
|||||
2020
Q3 | $1.69B | Buy |
|
|||||
2020
Q2 | $1.42B | Sell |
|
|||||
2020
Q1 | $1.48B | Sell |
|
|||||
2019
Q4 | $1.86B | Buy |
|
|||||
2019
Q3 | $1.61B | Sell |
|
|||||
2019
Q2 | $2.02B | Buy |
|
|||||
2019
Q1 | $1.93B | Sell |
|
|||||
2018
Q4 | $2.18B | Sell |
|
|||||
2018
Q3 | $2.45B | Buy |
|
|||||
2018
Q2 | $1.97B | Buy |
|
|||||
2018
Q1 | $1.88B | Buy |
|
|||||
2017
Q4 | $1.81B | Buy |
|
|||||
2017
Q3 | $1.68B | Sell |
|
|||||
2017
Q2 | $1.58B | Sell |
|
|||||
2017
Q1 | $1.7B | Buy |
|
|||||
2016
Q4 | $1.48B | Buy |
|
|||||
2016
Q3 | $1.33B | Buy |
|
|||||
2016
Q2 | $1.29B | Buy |
|
|||||
2016
Q1 | $1.06B | Sell |
|
|||||
2015
Q4 | $1.21B | Buy |
|
|||||
2015
Q3 | $1.12B | Buy |
|
|||||
2015
Q2 | $1.14B | Sell |
|
|||||
2015
Q1 | $1.22B | Buy |
|
|||||
2014
Q4 | $1.08B | Buy |
|
|||||
2014
Q3 | $1.02B | Sell |
|
|||||
2014
Q2 | $1.02B | Buy |
|
|||||
2014
Q1 | $999M | Buy |
|
|||||
2013
Q4 | $945M | Buy |
|
|||||
2013
Q3 | $879M | Sell |
|
|||||
2013
Q2 | $1.11B | Buy |
|